| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 04/03/2003 | WO2003026575A2 Molecules specific for npff receptors and uses thereof |
| 04/03/2003 | WO2002057413A3 Peptides for activation and inhibition of delta pkc |
| 04/03/2003 | US20030065210 Reductive alkylation of aspartame with aldehyde |
| 04/03/2003 | US20030065193 Antiinflammatory agents; antihistamines; antidiabetic agents |
| 04/03/2003 | US20030065185 Antiinflammatory agents |
| 04/03/2003 | US20030064984 Anticancer agents; side effect reduction |
| 04/03/2003 | US20030064977 Viricides |
| 04/03/2003 | US20030064962 Protease inhibitor; viricide |
| 04/03/2003 | US20030064921 Glandular disorders; computer model |
| 04/03/2003 | US20030064410 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 04/03/2003 | US20030064077 Recombinant poxvirus cytomegalovirus, compositions, and uses |
| 04/03/2003 | CA2460541A1 Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer |
| 04/03/2003 | CA2456281A1 Pyrane derivatives as both ace- and nep- inhibitors |
| 04/02/2003 | EP1298210A1 Cocoa flavour precursor peptides |
| 04/02/2003 | EP1297830A1 Use of alpha- or beta-amino acids, of the corresponding esters or of dipeptides of these amino acids with histidine derivatives in the prevention or treatment of tissue damage caused by a atmospheric ozone |
| 04/02/2003 | EP1296999A2 Neuroactive peptides for treatment of hypoxia and related conditions |
| 04/02/2003 | EP1296948A2 Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same. |
| 04/02/2003 | EP1296947A1 $g(A) CRYSTALLINE FORM OF PERINDOPRIL TERT-BUTYLAMINE SALT |
| 04/02/2003 | EP1296678A2 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 04/02/2003 | EP0954519B1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 04/02/2003 | EP0885189B9 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |
| 04/02/2003 | EP0871464B1 Bradykinin analogs as selective thrombin inhibitors |
| 04/02/2003 | EP0865445B1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties |
| 04/02/2003 | EP0644772B1 Opioid peptides |
| 04/02/2003 | CN1407991A Solid sweetener compositions, liquid sweetener compositions and utilization thereof |
| 04/02/2003 | CN1407972A 4-pyrimidine-N-acyl-L-phenylalanines |
| 04/01/2003 | US6541641 Reacting a carbamate compound containing ester and hydroxy groups with thionyl chloride to form oxo-oxazoline derivatives; cyclization |
| 04/01/2003 | US6541634 Process for preparing growth hormone secretagogues |
| 04/01/2003 | US6541467 And at P1 have a six-membered heterocyclic ring having two ring nitrogen ring atoms and the remainder of the ring atoms carbon atoms. |
| 04/01/2003 | US6541454 Phosphonates, biphosphonates and pharmaceutical compositions containing them |
| 04/01/2003 | US6541002 Rendering a polypeptide capable of binding with virion by altering the polypeptide such that the altered polypeptide comprises a Vpr-binding region having specific amino acid sequence |
| 04/01/2003 | CA2043741C Endothelin antagonistic peptide derivatives |
| 03/27/2003 | WO2003025572A1 Arf and hdm2 interaction domains and methods of use thereof |
| 03/27/2003 | WO2003024932A1 Bis-amino acid sulfonamides as hiv protease inhibitors |
| 03/27/2003 | WO2003024924A1 Novel compounds and compositions as cathepsin inhibitors |
| 03/27/2003 | WO2002048157A3 Imidazolidinones and their related derivatives as hepatitis c virus ns3 protease inhibitors |
| 03/27/2003 | WO2002040508A3 Lactam dipeptide and its use in inhibiting beta-amyloid peptide release |
| 03/27/2003 | WO2002026774A3 Melanocortin receptor ligands |
| 03/27/2003 | WO2002026229A1 Airway mucus secretion inhibitors |
| 03/27/2003 | US20030060599 For therapy and prophylaxis of viral infection, such as HIV infection |
| 03/27/2003 | US20030060459 Diamines as modulators of chemokine receptor activity |
| 03/27/2003 | US20030060418 Serine protease inhibitors |
| 03/27/2003 | US20030060408 Metal-binding compounds and uses therefor |
| 03/27/2003 | US20030060399 A heat shock protein 20 (HSP20)-derived polypeptides for treating or inhibiting smooth muscle vasospasm, smooth muscle cell proliferation, migration, and vasoconstriction |
| 03/27/2003 | US20030059906 Block copolymers for multifunctional self-assembled systems |
| 03/27/2003 | US20030059765 Compositions and methods for providing a protein to a virion |
| 03/27/2003 | US20030059511 Sweetener compositions and uses thereof |
| 03/27/2003 | US20030059422 Tuftsin metallopeptide analogs and uses thereof |
| 03/27/2003 | CA2460125A1 Novel compounds and compositions as cathepsin inhibitors |
| 03/27/2003 | CA2423945A1 Restrainers of airway mucus secretion |
| 03/26/2003 | EP1296142A2 Calcium receptor active molecules |
| 03/26/2003 | EP1294747A2 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 03/26/2003 | EP1294744A2 Peptides that stimulate cell survival and axon regeneration |
| 03/26/2003 | EP1294743A2 Method of obtaining peptides with tissue-specific activity and pharmaceutical compositions on their basis |
| 03/26/2003 | EP1294742A2 Urokinase inhibitors |
| 03/26/2003 | EP1294741A2 Dipeptide inhibitors for the blood-clotting factor xa |
| 03/26/2003 | EP1294740A2 Chemically-modified antimicrobial peptides, compositions and methods of production and use |
| 03/26/2003 | EP1294689A1 Novel $g(b crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same |
| 03/26/2003 | EP1294404A2 Prodrug compounds with an oligopeptide having an isoleucine residue |
| 03/26/2003 | EP1294403A2 Tripeptide prodrug compounds |
| 03/26/2003 | EP1294395A1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR |
| 03/26/2003 | EP1100759B1 Transition metal complexes as linkers |
| 03/26/2003 | EP0885186B1 Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 03/26/2003 | EP0871653B1 Novel amino acid derivatives, methods of producing them, and pharmaceutical compounds containing these compounds |
| 03/26/2003 | EP0869969B1 PEPTIDE CONJUGATES, USE THEREOF AS A DRUG, AND COMPOSITIONS CONTAINING them |
| 03/26/2003 | EP0804418B1 Platelet aggregation inhibitors |
| 03/26/2003 | CN1406249A Enhancing the circulating half-life of antibody-based fusion proteins |
| 03/26/2003 | CN1406226A Novel malonic acid derivatives, process for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them |
| 03/26/2003 | CN1406223A Protease inhibitor and their pharmaceutical uses |
| 03/26/2003 | CN1103775C Vitronectin receptor antagonists, their preparation and use |
| 03/26/2003 | CN1103559C Sweetener composition improved in taste |
| 03/26/2003 | CN1103558C Sweetener salt |
| 03/25/2003 | CA2232749C Truncated glial cell line-derived neurotrophic factor |
| 03/20/2003 | WO2003022872A2 Crystal form of lisinopril monohydrate |
| 03/20/2003 | WO2003022871A2 Peptides having a c- terminal hydroxylamino group as inhibitors of dipeptidyl peptidase i |
| 03/20/2003 | WO2003022806A2 Cbi analogues of cc-1065 and the duocarmycins |
| 03/20/2003 | WO2002100845A8 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 03/20/2003 | WO2002014543A3 Process for detecting enzyme activity in an immunoassay |
| 03/20/2003 | WO2002009641A9 Promyostatin peptides and methods of using same |
| 03/20/2003 | WO2002002591A3 Peptides for use in culture media |
| 03/20/2003 | US20030055264 Processes for the preparation of oxo-oxazoline or alloamino acid derivatives |
| 03/20/2003 | US20030055261 Compounds with growth hormone releasing properties |
| 03/20/2003 | US20030055213 Peptide for use in the treatment of hypertension, asthma, cerebral disorders, angina pectoris, kidney and heart disorders |
| 03/20/2003 | US20030055052 FAP-activated anti-tumor compounds |
| 03/20/2003 | US20030055005 Gamma-secretase inhibitors |
| 03/20/2003 | US20030055004 GPE analogs and peptidominetics |
| 03/20/2003 | US20030055003 Administering copper chelator and activated protein C (APC) or protein C or agent that increases the synthesis of protein C in the animal, or both, an activator of protein C for therapy |
| 03/20/2003 | US20030055002 For cancer therapy |
| 03/20/2003 | US20030055000 Non-natural galanin receptor ligands |
| 03/20/2003 | CA2459308A1 Cbi analogues of cc-1065 and the duocarmycins |
| 03/19/2003 | EP1293495A1 Process for the preparation of bromoisophthalic acid compounds |
| 03/19/2003 | EP1292608A2 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses |
| 03/19/2003 | EP1292579A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 03/19/2003 | EP0772459B1 TECHNETIUM-99m LABELED IMAGING AGENTS |
| 03/19/2003 | CN1404487A High purity lipopeptides, lipopeptide micelles, process for preparing same |
| 03/18/2003 | US6534658 Intermediates for producing pharmaceuticals |
| 03/18/2003 | US6534650 Benzisoxazole and 4-amidino-3-hydroxyphenyl chemical intermediates |
| 03/18/2003 | US6534640 Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids |
| 03/18/2003 | US6534536 Alkylsulfonamido heterocyclic thrombin inhibitors |
| 03/18/2003 | US6534530 Administering (benzo)thiazole peptidomimetic as viricide; protease inhibitors |